Wilmington, Delaware–based Enovis designed the STAR PSI system to provide a personalized preoperative plan for each patient. Surgeons receive and review a 3D visualization of the patient’s ankle joint. This includes information about existing implants or bone defects.
The DJO parent company said in a news release that this allows the surgeons to plan for the total ankle replacement case. STAR PSI features an updated and simplified surgical technique. Enovis said this could potentially reduce operative time during total ankle replacement cases.
Stryker divested the STAR Ankle platform to Enovis in 2020 as it prepared to buy Wright Medical.
“Today is an exciting day for our customers and patients,” said Gary Justak, president of Enovis Foot & Ankle. “We acquired the STAR Ankle just two years ago, and the FDA approval of STAR PSI is just one example of our team’s commitment and investment to taking this best-in-class product to the level it deserves. Surgeons now have leading pre-operative planning and cutting guides, that when paired with years of proven, clinical data, set STAR Ankle up for a brilliant future.”
Plans for the STAR PSI platform
Enovis plans to enter STAR PSI into early product surveillance this month. It intends to fully launch the platform by the end of March 2023.
STAR PSI joins a handful of Enovis products introduced this year. In November, the company launched its DynaNail Helix system for hindfoot fusions. It also introduced the Arsenal Ankle plating system, another piece of its growing foot and ankle portfolio.